Spinal Implants and Surgery Devices Market Report by Product, Type of Surgery, End User, and Region 2025-2033
척추 임플란트 및 수술 기기 세계 시장 규모는 2024년 124억 달러에 달했습니다. 향후 IMARC Group은 2033년까지 시장 규모가 180억 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 3.98%에 달할 것으로 전망하고 있습니다.
척추 임플란트 및 수술 기기는 척추의 변형이나 장애를 치료하는 데 사용되는 의료기기를 말합니다. 이러한 임플란트는 티타늄, 티타늄 합금, 스테인리스 스틸 등의 생체적합성 재료를 사용하여 제조되며, 일반적으로 융합형 임플란트와 비융합형 임플란트의 두 가지 종류가 있습니다. 융합형 임플란트에는 로드, 플레이트, 스크류, 인터바디 케이지 등이 있습니다. 반면, 비유합형 임플란트에는 인공 추간판, 확장 가능한 막대, 성장 보존 장치 등이 있습니다. 이 외에도 흉추, 요추, 경추 고정장치와 척추 감압장치도 다양한 치료 시술에 사용되고 있습니다. 이 임플란트는 두 척추의 움직임을 촉진하고, 척추의 안정성을 향상시키고, 변형을 교정하는 데 사용됩니다.
디스크 퇴행성 질환, 척추측만증, 후만증, 척추 전방전위증과 같은 척추 질환의 유병률 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 이는 대다수의 노동 인구가 좌식 생활 방식과 바쁜 스케줄로 인해 비만, 요통, 자세 관련 문제 및 기타 퇴행성 척추 질환의 발생률이 크게 증가하고 있기 때문입니다. 또한, 골격이 성숙하지 않은 환자, 특히 소아를 위해 특별히 고안된 효율적인 성장 보존 기구의 개발도 시장 성장에 기여하고 있습니다. 또한, 첨단 뼈 이식 제품의 개발, 금속보다 내구성이 높은 재료의 사용 등 다양한 기술 발전도 시장 성장을 촉진하고 있습니다. 노인 인구의 증가와 최소침습(MI) 척추 수술의 보급과 같은 다른 요인들도 시장을 더욱 견인할 것으로 예상됩니다.
본 보고서에서 다루는 주요 질문
- 세계 척추 임플란트 및 수술 기기 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 성장할 것인가?
- COVID-19가 세계 척추 임플란트 및 수술 기기 시장에 미치는 영향은?
- 주요 지역 시장이란?
- 제품별 시장 분석은?
- 수술 유형별 시장 분석은?
- 최종사용자별 시장 분석은 어떻게 되는가?
- 산업 가치사슬의 다양한 단계는 무엇인가?
- 업계의 주요 촉진요인과 과제는 무엇인가?
- 세계 척추 임플란트 및 수술 기기 시장의 구조와 주요 업체는?
- 업계 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 척추 임플란트 및 수술 기기 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품별
- 흉추 고정 기기 및 요추 고정 기기
- 경추 고정 기기
- 척추 바이오로직스
- 척추압박골절 치료 기기
- 척추 감압 기기
- 비융합 기기
- 척추뼈 자극기
제7장 시장 내역 : 수술 유형별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Abbott Laboratories
- B. Braun(B. Braun Holding GmbH & Co. KG)
- Boston Scientific
- Depuy Synthes(Johnson & Johnson)
- Exactech Inc.(Choice Spine)
- Globus Medical Inc.
- Integra LifeSciences Holdings Corporation
- Medtronic Plc
- Nuvasive Inc.(Smith & Nephew Plc)
- Orthofix Medical Inc.
- RTI Surgical Inc.
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
ksm
The global spinal implants and surgery devices market size reached USD 12.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.98% during 2025-2033.
Spinal implants and surgery devices refer to the medical equipment used to treat spinal deformities and disorders. These implants are manufactured using biocompatible materials, such as titanium, titanium-alloy and stainless-steel, and are commonly available in two variants, namely fusion and non-fusion implants. Fusion implants include rods, plates, screws and interbody cages. On the other hand, non-fusion implants include artificial discs, expandable rods and growth sparing devices. Apart from this, thoracic, lumbar and cervical fusion and spinal decompression devices are also used for various treatment procedures. These implants are used to facilitate the movement of two vertebrae, improve the stability of the spine and correct deformities.
The increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, kyphosis and spondylolisthesis, is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the majority of the working population, which, in turn, is significantly increasing the incidences of obesity, back pain, posture-related problems and other degenerative spinal conditions. Furthermore, the development of efficient growth-sparing devices, which are specifically designed for patients, especially children, who have not reached skeletal maturity is also contributing to the market growth. Additionally, various technological advancements, such as the development of advanced bone grafting products and the utilization of materials that are more durable than metal, are favoring the growth of the market. Other factors, including the rising geriatric population and widespread adoption of minimally invasive (MI) spinal surgeries, are expected to drive the market further.
Key Market Segmentation:
Breakup by Product:
- Thoracic Fusion and Lumbar Fusion Devices
- Cervical Fusion Devices
- Spine Biologics
- Vertebral Compression Fracture Treatment Devices
- Spinal Decompression Devices
- Non-Fusion Devices
- Spine Bone Stimulators
Breakup by Type of Surgery:
- Open Surgeries
- Minimally Invasive Surgeries
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, Depuy Synthes (Johnson & Johnson), Exactech Inc. (Choice Spine), Globus Medical Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Nuvasive Inc. (Smith & Nephew Plc), Orthofix Medical Inc., RTI Surgical Inc., Stryker Corporation and Zimmer Biomet Holdings Inc.
Key Questions Answered in This Report:
- How has the global spinal implants and surgery devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global spinal implants and surgery devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the type of surgery?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global spinal implants and surgery devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Spinal Implants and Surgery Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Thoracic Fusion and Lumbar Fusion Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Cervical Fusion Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Spine Biologics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Vertebral Compression Fracture Treatment Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Spinal Decompression Devices
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Non-Fusion Devices
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Spine Bone Stimulators
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Type of Surgery
- 7.1 Open Surgeries
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Minimally Invasive Surgeries
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgery Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 B. Braun (B. Braun Holding GmbH & Co. KG)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Boston Scientific
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Depuy Synthes (Johnson & Johnson)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Exactech Inc. (Choice Spine)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Globus Medical Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Integra LifeSciences Holdings Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Medtronic Plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Nuvasive Inc. (Smith & Nephew Plc)
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Orthofix Medical Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 RTI Surgical Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Stryker Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Zimmer Biomet Holdings Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
